We are live on ! Find out more
VAM

Veritas Asset Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 3.19%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
-3.19%
3 Year Est. Return
+26.61%
5 Year Est. Return
+23.16%
10 Year Est. Return
+201.18%
AUM
$11.1B
AUM Growth
+$1.68B
Cap. Flow
+$862M
Cap. Flow %
7.78%
Top 10 Hldgs %
71.6%
Holding
32
New
4
Increased
16
Reduced
4
Closed
4

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$742M
2
TMO icon
Thermo Fisher Scientific
TMO
+$175M
3
CERN
Cerner Corp
CERN
+$171M
4
CVS icon
CVS Health
CVS
+$43.7M
5
CMCSA icon
Comcast
CMCSA
+$43.6M

Top Sells

Rank Stock Value
1
HAL icon
Halliburton
HAL
+$412M
2
VAR
Varian Medical Systems, Inc.
VAR
+$184M
3
SLB icon
SLB Ltd
SLB
+$30.5M
4
PFE icon
Pfizer
PFE
+$10.8M
5
NTES icon
NetEase
NTES
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 37.35%
2 Communication Services 31%
3 Technology 18.65%
4 Financials 6.51%
5 Real Estate 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBPO
26
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$2M 0.02%
+20,000
New +$2.14M
GSUM
27
DELISTED
Gridsum Holding Inc.
GSUM
$266K ﹤0.01%
20,000
– –
HAL icon
28
Halliburton
HAL
$26.4B
– –
-7,612,603
Closed -$412M
NTES icon
29
NetEase
NTES
$84.4B
– –
-241,500
Closed -$10.4M
SLB icon
30
SLB Ltd
SLB
$72.6B
– –
-363,000
Closed -$30.5M
VAR
31
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-2,337,831
Closed -$184M
1
2

Similar funds

TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $5.87B AUM 24.95% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return

Veritas Asset Management's Q1 2017 Portfolio in Review

As of Q1 2017, Veritas Asset Management held 32 positions worth $11.1B, up 18% from $9.4B the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Veritas Asset Management deployed $862M of net new capital in Q1 2017, opening 4 new positions and adding to 16 existing holdings. Its largest new stake was Allergan plc: 3,186,586 shares worth $761M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 31% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Pfizer, an estimated $10.8M trimmed.

  • Veritas Asset Management's largest Q1 2017 buy was Allergan plc: 3,186,586 shares worth $761M.
  • Veritas Asset Management added most to CVS Health in Q1 2017, an estimated $43.7M increase.
  • Veritas Asset Management's biggest Q1 2017 reduction was Pfizer, cutting an estimated $10.8M.
  • Veritas Asset Management fully exited Halliburton in Q1 2017, selling an estimated $412M.
  • Veritas Asset Management's ten largest holdings make up 72% of its $11.1B portfolio in Q1 2017.
  • Veritas Asset Management opened 4 new positions and closed 4 in Q1 2017.
  • Veritas Asset Management's portfolio value rose 18% quarter-over-quarter to $11.1B.

Based on Veritas Asset Management's 13F filing for Q1 2017, filed 11 May 2017.